|
| Promalignant properties of STAT3 during chronic inflammation |
|
https://doi.org/10.18632/oncotarget.482
Marco Demaria, and Valeria Poli
|
| 359-360 |
|
| Attacking tumor cells with a dual ligand for innate immune receptors |
|
https://doi.org/10.18632/oncotarget.484
Johan Garaude, and J. Magarian Blander
|
| 361-362 |
|
| Accelerating cancer evolution: a dark side of SIRT1 in genome maintenance |
|
https://doi.org/10.18632/oncotarget.487
WenYong Chen
|
| 363-364 |
|
| Targeting Cancer Gene Therapy with Magnetic Nanoparticles |
|
https://doi.org/10.18632/oncotarget.490
Charles Li, Linda Li, and Andrew C. Keate
|
| 365-370 |
|
| Two hits are better than one: targeting both phosphatidylinositol 3kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment |
|
https://doi.org/10.18632/oncotarget.477
Alberto M. Martelli, Francesca Chiarini, Camilla Evangelisti, Alessandra Cappellini, Francesca Buontempo, Daniela Bressanin, Milena Fini, and James A. McCubrey
|
| 371-394 |
|
| Metformininduced preferential killing of breast cancer initiating CD44+CD24/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
|
https://doi.org/10.18632/oncotarget.488
SÃlvia CufÃ, Bruna Corominas-Faja, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Joan Dorca, Joaquim Bosch-Barrera, Begoña Martin-Castillo, and Javier A Menendez
|
| 395-398 |
|
| Aggressiveness of human melanoma xenograft models is promoted by aneuploidydriven gene expression deregulation |
|
https://doi.org/10.18632/oncotarget.473
Veronique Mathieu, Christine Pirker, Wolfgang M Schmidt, Sabine Spiegl-Kreinecker, Daniela Lötsch, Petra Heffeter, Balazs Hegedus, Michael Grusch, Robert Kiss, and Walter Berger
|
| 399-413 |
|
| Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance |
|
https://doi.org/10.18632/oncotarget.519
Daniel J. O'Shannessy, Gordon Yu, Robert Smale, Yao-Shi Fu, Sunil Singhal, Robert P. Thiel, Elizabeth B. Somers, and Anil Vachani
|
| 414-425 |
|
| Properties of MechanoTransduction via Simulated Microgravity and its Effects on Intracellular Trafficking of VEGFR’s |
|
https://doi.org/10.18632/oncotarget.472
Andrew Puca, Giuseppe Russo, and Antonio Giordano
|
| 426-434 |
|
| Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling Glucose regulatory protein 78 and AMPK |
|
https://doi.org/10.18632/oncotarget.483
Prabodh K. Kandala, and Sanjay K. Srivastava
|
| 435-449 |
|
| Methylation profiling of normal individuals reveals mosaic promoter methylation of cancerassociated genes |
|
https://doi.org/10.18632/oncotarget.480
Lasse S. Kristensen, Michael P. Raynor, Ida L. Candiloro, and Alexander Dobrovic
|
| 450-461 |
|
| On the presence and role of human genebody DNA methylation |
|
https://doi.org/10.18632/oncotarget.497
Daudi Jjingo, Andrew B. Conley, Soojin V. Yi, Victoria V. Lunyak, and I. King Jordan
|
| 462-474 |
|
| Singular v Dual Inhibition of SNF2L and Its Isoform SNF2LT Have Similar Effects on DNA Damage but Opposite Effects on the DNA Damage Response Cancer Cell Growth Arrest and Apoptosis |
|
https://doi.org/10.18632/oncotarget.479
Yin Ye, Yi Xiao, Wenting Wang, Jian-Xin Gao, Kurtis Yearsley, Quintao Yan, and Sanford H. Barsky
|
| 475-489 |
|
| BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients |
|
https://doi.org/10.18632/oncotarget.481
Thomas Cluzeau, Guillaume Robert, Nicolas Mounier, Jean Michel Karsenti, Maeva Dufies, Alexandre Puissant, Arnaud Jacquel, Aline Renneville, Claude Preudhomme, Jill Patrice Cassuto, Sophie Raynaud, Frederic Luciano, and Patrick Auberger
|
| 490-501 |
|
| Comprehensive Assessment of Potential Multiple Myeloma Immunoglobulin Heavy Chain VDJ Intraclonal Variation Using Massively Parallel Pyrosequencing |
|
https://doi.org/10.18632/oncotarget.469
Renee C. Tschumper, Yan W. Asmann, Asif Hossain, Paul M. Huddleston, Xiaosheng Wu, Angela Dispenzieri, Bruce W. Eckloff, and Diane F. Jelinek
|
| 502-513 |
